Pseudomonas aeruginosa: So many virulence factors, so little time*
Author:
- Alan R. HauserAHAlan R. Hauser
- 1 September 2011
- journal article
- editorial
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 39 (9) , 2193-2194
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III SecretionAntimicrobial Agents and Chemotherapy, 2010
- The type III secretion system of Pseudomonas aeruginosa: infection by injectionNature Reviews Microbiology, 2009
- Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies*Critical Care Medicine, 2009
- Persistent Infection with Pseudomonas aeruginosa in Ventilator-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Pseudomonas aeruginosa lipopolysaccharide: A major virulence factor, initiator of inflammation and target for effective immunityInternational Journal of Medical Microbiology, 2007
- Quorum Sensing Negatively Controls Type III Secretion Regulon Expression in Pseudomonas aeruginosa PAO1Journal of Bacteriology, 2005
- Quorum sensing: the power of cooperation in the world of PseudomonasEnvironmental Microbiology, 2005
- O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosaJournal of Clinical Microbiology, 2003
- Generation and Characterization of a Protective Monoclonal Antibody toPseudomonas aeruginosaPcrVThe Journal of Infectious Diseases, 2002
- Type III Protein Secretion Is Associated with Death in Lower Respiratory and SystemicPseudomonas aeruginosaInfectionsThe Journal of Infectious Diseases, 2001